LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 76 filers reported holding LYELL IMMUNOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $110,639,000 | +12.4% | 15,093,969 | 0.0% | 42.56% | +56.4% |
| Q2 2022 | $98,413,000 | +29.1% | 15,093,969 | 0.0% | 27.22% | +35.7% |
| Q1 2022 | $76,225,000 | -34.8% | 15,093,969 | 0.0% | 20.06% | +37.8% |
| Q4 2021 | $116,827,000 | -48.0% | 15,093,969 | -0.5% | 14.55% | -52.5% |
| Q3 2021 | $224,483,000 | -8.9% | 15,167,757 | 0.0% | 30.66% | -5.2% |
| Q2 2021 | $246,324,000 | – | 15,167,757 | – | 32.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $156,056,000 | 45.49% |
| Foresite Capital Management IV, LLC | 13,282,181 | $102,804,000 | 21.15% |
| Apoletto Ltd | 15,093,969 | $116,827,000 | 14.55% |
| SB Management Ltd | 3,500,000 | $27,090,000 | 2.68% |
| HSG Holding Ltd | 3,045,997 | $23,576,000 | 2.11% |
| MIC Capital Management UK LLP | 1,320,000 | $10,217,000 | 1.95% |
| Alphabet Inc. | 5,865,125 | $45,396,000 | 1.10% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $12,754,000 | 0.80% |
| Adero Partners, LLC | 491,372 | $3,803,000 | 0.62% |
| Ergoteles LLC | 1,008,428 | $7,805,000 | 0.30% |